Neurodegeneration in equine grass sickness is not attributable to niacin deficiency.

This research study explores the possibility of niacin (vitamin B3) deficiency contributing to neurodegeneration in equine grass sickness (EGS) but finds no significant link. The study also compares levels of vitamins B1, B2, and B6 in healthy and EGS-affected horses, and again, notes no significant differences.

Introduction

• The research is based on equine grass sickness (EGS), a disease with unknown causes that affects horses. The hypothesis of the researchers was that a sudden lack of niacin, or vitamin B3, could potentially result in neurodegeneration in horses suffering from EGS. This was proposed because niacin plays an essential role in maintaining neural stability.
• The idea came from the possibility that horses consuming pasture mycotoxigenic fungi could experience a deficiency in niacin due to the niacin antagonists produced by these fungi. The study was designed to compare the niacin levels of EGS horses with those grazing horses not affected by EGS.
• Additionally, the study sought to determine if the levels of other vitamins like B1, B2, and B6 differed in horses with EGS compared to their healthy counterparts.

Methodology

• This study is a case-control research design. The research compared indices of niacin status, specifically the ratio of erythrocyte nicotinamide adenine dinucleotide to nicotinamide adenine dinucleotide phosphate (NAD:NADP ratio), and the erythrocyte concentrations of NAD and NADP in blood from EGS affected horses and healthy grazing horses.
• Levels of vitamins B1, B2, and B6 in the horses’ blood were also measured and compared.

Results

• The primary result demonstrated no significant differences between the EGS and control groups in terms of the NAD:NADP ratio, which is a key index for determining niacin status.
• The research did find a significant increase (median value 25% higher) in the concentrations of NADP in EGS horses. However, other vitamin levels, B1, B2, and B6, did not show any significant differences between the control and EGS groups.

Conclusion

• Despite the distinct findings, the researchers caution that the interpretation of the results is somewhat restricted due to the lack of predefined reference ranges for equines for many of the examined analytes. Furthermore, they mention that the sample size was relatively small, potentially limiting the applicability of the results.
• In conclusion, the study found no significant evidence to support the hypothesis that a deficiency in niacin contributes to neurodegeneration in equine grass sickness.